Incidence of chronic disease and lipid profile in veteran rugby athletes

Mike Climstein, Joe Walsh, John Best, Ian Timothy Heazlewood, Stephen Burke, Jyrki Kettunen, Kent Adams, Mark DeBeliso

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Recently, the health of retired National Football League players, particularly lineman has been investigated. A number of studies have reported increased cardiometabolic risk, premature cardiovascular disease and incidence of type 2 diabetes. Rugby union players have somatotypes very similar to National Football League players which suggests that rugby players may have similar health risks. The International Golden Oldies World Rugby Festival (GORF) provided a unique opportunity to investigate the demographics of veteran rugby players. METHODOLOGIES: A cross-sectional, observational study was completed using an online web-based questionnaire that consisted of medical history and physiological measures. Data analysis was completed using a one sample t-test (<50yrs versus >50yrs) and Chi-square test. RESULTS: A total of 216 veteran rugby competitors (response rate = 6.8%) representing 10 countries, aged 35-72 yrs (mean 51.2, S.D. ±8.0), participated in the online survey. As a group, the incidence of current smokers was low at 8.8% (avg 72.4 cigs/wk) whilst the percentage consuming alcohol was high (93.1% (avg 11.2 drinks/wk). Competitors reported the following top six chronic diseases/disorders; hypertension (18.6%), arthritis (OA/RA, 11.5%), asthma (9.3%), hyperlipidemia (8.2%), diabetes (all types, 7.5%) and gout (6%), there were significant differences between groups with regard to cancer (all types) and migraines. When compared to the Australian general population (Australian Bureau of Statistics data, n=18,000), GORF competitors had a significantly lower incidence of anxiety (p<0.01), arthritis (p<0.06), depression (p<.01) however, a significantly higher incidence of diabetes (p<0.03) and hypertension (p<0.01). The GORF competitors also reported taking the following prescribed medications; antihypertensive (13%), hypolipidemics (8%), non-steroidal anti-inflammatory (6%), and anticoagulants (4%). Significant differences between groups were observed in antihypertensives, anticoagulants and hypolipidemics. There were significant (p<0.05) differences between groups (<50yrs versus >50yrs) with regard to height (180 vs 177cm), weight (97.6 vs 93.1Kg's), BMI (30 vs 29.7kg/m2) and waist circumference (85.7 vs 93.1cm) however, there were no differences in subsequent parameters of systolic blood pressure, diastolic blood pressure, total cholesterol, HDL-C, LDL-C, triglycerides-C or fasting plasma glucose. CONCLUSIONS: This represents the first collection of demographics on this cohort. GORF participants demonstrated increased cardiometabolic risk with regard to the incidence of hypercholesterolemia, hypertension and type 2 diabetes. Preventative strategies should be developed to reduce this risk with education of these risks for future participants.

Original languageEnglish
Pages (from-to)362-366
Number of pages5
JournalInternational Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering
Volume5
Issue number8
Publication statusPublished - Aug 2011

Fingerprint

Lipids
Medical problems
Blood pressure
Health risks
Cholesterol
Glucose
Alcohols
Education
Health
Statistics
Plasmas

Cite this

Climstein, M., Walsh, J., Best, J., Heazlewood, I. T., Burke, S., Kettunen, J., ... DeBeliso, M. (2011). Incidence of chronic disease and lipid profile in veteran rugby athletes. International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering, 5(8), 362-366.
Climstein, Mike ; Walsh, Joe ; Best, John ; Heazlewood, Ian Timothy ; Burke, Stephen ; Kettunen, Jyrki ; Adams, Kent ; DeBeliso, Mark. / Incidence of chronic disease and lipid profile in veteran rugby athletes. In: International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering. 2011 ; Vol. 5, No. 8. pp. 362-366.
@article{c0c6575b154140c4b7efe2100758379d,
title = "Incidence of chronic disease and lipid profile in veteran rugby athletes",
abstract = "Recently, the health of retired National Football League players, particularly lineman has been investigated. A number of studies have reported increased cardiometabolic risk, premature cardiovascular disease and incidence of type 2 diabetes. Rugby union players have somatotypes very similar to National Football League players which suggests that rugby players may have similar health risks. The International Golden Oldies World Rugby Festival (GORF) provided a unique opportunity to investigate the demographics of veteran rugby players. METHODOLOGIES: A cross-sectional, observational study was completed using an online web-based questionnaire that consisted of medical history and physiological measures. Data analysis was completed using a one sample t-test (<50yrs versus >50yrs) and Chi-square test. RESULTS: A total of 216 veteran rugby competitors (response rate = 6.8{\%}) representing 10 countries, aged 35-72 yrs (mean 51.2, S.D. ±8.0), participated in the online survey. As a group, the incidence of current smokers was low at 8.8{\%} (avg 72.4 cigs/wk) whilst the percentage consuming alcohol was high (93.1{\%} (avg 11.2 drinks/wk). Competitors reported the following top six chronic diseases/disorders; hypertension (18.6{\%}), arthritis (OA/RA, 11.5{\%}), asthma (9.3{\%}), hyperlipidemia (8.2{\%}), diabetes (all types, 7.5{\%}) and gout (6{\%}), there were significant differences between groups with regard to cancer (all types) and migraines. When compared to the Australian general population (Australian Bureau of Statistics data, n=18,000), GORF competitors had a significantly lower incidence of anxiety (p<0.01), arthritis (p<0.06), depression (p<.01) however, a significantly higher incidence of diabetes (p<0.03) and hypertension (p<0.01). The GORF competitors also reported taking the following prescribed medications; antihypertensive (13{\%}), hypolipidemics (8{\%}), non-steroidal anti-inflammatory (6{\%}), and anticoagulants (4{\%}). Significant differences between groups were observed in antihypertensives, anticoagulants and hypolipidemics. There were significant (p<0.05) differences between groups (<50yrs versus >50yrs) with regard to height (180 vs 177cm), weight (97.6 vs 93.1Kg's), BMI (30 vs 29.7kg/m2) and waist circumference (85.7 vs 93.1cm) however, there were no differences in subsequent parameters of systolic blood pressure, diastolic blood pressure, total cholesterol, HDL-C, LDL-C, triglycerides-C or fasting plasma glucose. CONCLUSIONS: This represents the first collection of demographics on this cohort. GORF participants demonstrated increased cardiometabolic risk with regard to the incidence of hypercholesterolemia, hypertension and type 2 diabetes. Preventative strategies should be developed to reduce this risk with education of these risks for future participants.",
author = "Mike Climstein and Joe Walsh and John Best and Heazlewood, {Ian Timothy} and Stephen Burke and Jyrki Kettunen and Kent Adams and Mark DeBeliso",
year = "2011",
month = "8",
language = "English",
volume = "5",
pages = "362--366",
journal = "International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering",
issn = "1752-6418",
publisher = "Inderscience Enterprises Ltd",
number = "8",

}

Climstein, M, Walsh, J, Best, J, Heazlewood, IT, Burke, S, Kettunen, J, Adams, K & DeBeliso, M 2011, 'Incidence of chronic disease and lipid profile in veteran rugby athletes' International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering, vol. 5, no. 8, pp. 362-366.

Incidence of chronic disease and lipid profile in veteran rugby athletes. / Climstein, Mike; Walsh, Joe; Best, John; Heazlewood, Ian Timothy; Burke, Stephen; Kettunen, Jyrki; Adams, Kent; DeBeliso, Mark.

In: International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering, Vol. 5, No. 8, 08.2011, p. 362-366.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Incidence of chronic disease and lipid profile in veteran rugby athletes

AU - Climstein, Mike

AU - Walsh, Joe

AU - Best, John

AU - Heazlewood, Ian Timothy

AU - Burke, Stephen

AU - Kettunen, Jyrki

AU - Adams, Kent

AU - DeBeliso, Mark

PY - 2011/8

Y1 - 2011/8

N2 - Recently, the health of retired National Football League players, particularly lineman has been investigated. A number of studies have reported increased cardiometabolic risk, premature cardiovascular disease and incidence of type 2 diabetes. Rugby union players have somatotypes very similar to National Football League players which suggests that rugby players may have similar health risks. The International Golden Oldies World Rugby Festival (GORF) provided a unique opportunity to investigate the demographics of veteran rugby players. METHODOLOGIES: A cross-sectional, observational study was completed using an online web-based questionnaire that consisted of medical history and physiological measures. Data analysis was completed using a one sample t-test (<50yrs versus >50yrs) and Chi-square test. RESULTS: A total of 216 veteran rugby competitors (response rate = 6.8%) representing 10 countries, aged 35-72 yrs (mean 51.2, S.D. ±8.0), participated in the online survey. As a group, the incidence of current smokers was low at 8.8% (avg 72.4 cigs/wk) whilst the percentage consuming alcohol was high (93.1% (avg 11.2 drinks/wk). Competitors reported the following top six chronic diseases/disorders; hypertension (18.6%), arthritis (OA/RA, 11.5%), asthma (9.3%), hyperlipidemia (8.2%), diabetes (all types, 7.5%) and gout (6%), there were significant differences between groups with regard to cancer (all types) and migraines. When compared to the Australian general population (Australian Bureau of Statistics data, n=18,000), GORF competitors had a significantly lower incidence of anxiety (p<0.01), arthritis (p<0.06), depression (p<.01) however, a significantly higher incidence of diabetes (p<0.03) and hypertension (p<0.01). The GORF competitors also reported taking the following prescribed medications; antihypertensive (13%), hypolipidemics (8%), non-steroidal anti-inflammatory (6%), and anticoagulants (4%). Significant differences between groups were observed in antihypertensives, anticoagulants and hypolipidemics. There were significant (p<0.05) differences between groups (<50yrs versus >50yrs) with regard to height (180 vs 177cm), weight (97.6 vs 93.1Kg's), BMI (30 vs 29.7kg/m2) and waist circumference (85.7 vs 93.1cm) however, there were no differences in subsequent parameters of systolic blood pressure, diastolic blood pressure, total cholesterol, HDL-C, LDL-C, triglycerides-C or fasting plasma glucose. CONCLUSIONS: This represents the first collection of demographics on this cohort. GORF participants demonstrated increased cardiometabolic risk with regard to the incidence of hypercholesterolemia, hypertension and type 2 diabetes. Preventative strategies should be developed to reduce this risk with education of these risks for future participants.

AB - Recently, the health of retired National Football League players, particularly lineman has been investigated. A number of studies have reported increased cardiometabolic risk, premature cardiovascular disease and incidence of type 2 diabetes. Rugby union players have somatotypes very similar to National Football League players which suggests that rugby players may have similar health risks. The International Golden Oldies World Rugby Festival (GORF) provided a unique opportunity to investigate the demographics of veteran rugby players. METHODOLOGIES: A cross-sectional, observational study was completed using an online web-based questionnaire that consisted of medical history and physiological measures. Data analysis was completed using a one sample t-test (<50yrs versus >50yrs) and Chi-square test. RESULTS: A total of 216 veteran rugby competitors (response rate = 6.8%) representing 10 countries, aged 35-72 yrs (mean 51.2, S.D. ±8.0), participated in the online survey. As a group, the incidence of current smokers was low at 8.8% (avg 72.4 cigs/wk) whilst the percentage consuming alcohol was high (93.1% (avg 11.2 drinks/wk). Competitors reported the following top six chronic diseases/disorders; hypertension (18.6%), arthritis (OA/RA, 11.5%), asthma (9.3%), hyperlipidemia (8.2%), diabetes (all types, 7.5%) and gout (6%), there were significant differences between groups with regard to cancer (all types) and migraines. When compared to the Australian general population (Australian Bureau of Statistics data, n=18,000), GORF competitors had a significantly lower incidence of anxiety (p<0.01), arthritis (p<0.06), depression (p<.01) however, a significantly higher incidence of diabetes (p<0.03) and hypertension (p<0.01). The GORF competitors also reported taking the following prescribed medications; antihypertensive (13%), hypolipidemics (8%), non-steroidal anti-inflammatory (6%), and anticoagulants (4%). Significant differences between groups were observed in antihypertensives, anticoagulants and hypolipidemics. There were significant (p<0.05) differences between groups (<50yrs versus >50yrs) with regard to height (180 vs 177cm), weight (97.6 vs 93.1Kg's), BMI (30 vs 29.7kg/m2) and waist circumference (85.7 vs 93.1cm) however, there were no differences in subsequent parameters of systolic blood pressure, diastolic blood pressure, total cholesterol, HDL-C, LDL-C, triglycerides-C or fasting plasma glucose. CONCLUSIONS: This represents the first collection of demographics on this cohort. GORF participants demonstrated increased cardiometabolic risk with regard to the incidence of hypercholesterolemia, hypertension and type 2 diabetes. Preventative strategies should be developed to reduce this risk with education of these risks for future participants.

UR - http://www.scopus.com/inward/record.url?scp=80052186178&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 362

EP - 366

JO - International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering

JF - International Journal of Medical, Health, Biomedical, Bioengineering and Pharmaceutical Engineering

SN - 1752-6418

IS - 8

ER -